rs3791767
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_016467.5(ORMDL1):c.326+376T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.225 in 156,426 control chromosomes in the GnomAD database, including 4,170 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.23 ( 4108 hom., cov: 32)
Exomes 𝑓: 0.17 ( 62 hom. )
Consequence
ORMDL1
NM_016467.5 intron
NM_016467.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.387
Publications
17 publications found
Genes affected
ORMDL1 (HGNC:16036): (ORMDL sphingolipid biosynthesis regulator 1) Involved in ceramide metabolic process. Acts upstream of or within negative regulation of ceramide biosynthetic process. Located in endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.281 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.227 AC: 34461AN: 151972Hom.: 4100 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
34461
AN:
151972
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.170 AC: 736AN: 4336Hom.: 62 Cov.: 0 AF XY: 0.163 AC XY: 367AN XY: 2250 show subpopulations
GnomAD4 exome
AF:
AC:
736
AN:
4336
Hom.:
Cov.:
0
AF XY:
AC XY:
367
AN XY:
2250
show subpopulations
African (AFR)
AF:
AC:
29
AN:
128
American (AMR)
AF:
AC:
51
AN:
280
Ashkenazi Jewish (ASJ)
AF:
AC:
28
AN:
138
East Asian (EAS)
AF:
AC:
30
AN:
132
South Asian (SAS)
AF:
AC:
31
AN:
268
European-Finnish (FIN)
AF:
AC:
17
AN:
138
Middle Eastern (MID)
AF:
AC:
2
AN:
20
European-Non Finnish (NFE)
AF:
AC:
508
AN:
3024
Other (OTH)
AF:
AC:
40
AN:
208
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
34
68
103
137
171
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.227 AC: 34488AN: 152090Hom.: 4108 Cov.: 32 AF XY: 0.225 AC XY: 16744AN XY: 74364 show subpopulations
GnomAD4 genome
AF:
AC:
34488
AN:
152090
Hom.:
Cov.:
32
AF XY:
AC XY:
16744
AN XY:
74364
show subpopulations
African (AFR)
AF:
AC:
11828
AN:
41476
American (AMR)
AF:
AC:
3818
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
741
AN:
3472
East Asian (EAS)
AF:
AC:
1172
AN:
5176
South Asian (SAS)
AF:
AC:
827
AN:
4822
European-Finnish (FIN)
AF:
AC:
2058
AN:
10586
Middle Eastern (MID)
AF:
AC:
75
AN:
294
European-Non Finnish (NFE)
AF:
AC:
13386
AN:
67962
Other (OTH)
AF:
AC:
459
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1350
2699
4049
5398
6748
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
364
728
1092
1456
1820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
760
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.